Market Overview

3SBIO Retains Jefferies On September 12 Proposal to Go Private

Related JEF
Vetr Crowd Downgrades NetEase
IPO Outlook: Inotek's Vision For The Future

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the special committee of independent directors (the "Independent Committee") has retained Jefferies & Company, Inc. as the Independent Committee's financial advisor.

Posted-In: News Guidance M&A


Related Articles (SSRX + JEF)

View Comments and Join the Discussion!

Partner Center